Dr. Davis closed his message by expressing hope and confidence in the future-both for the graduating class of 2025 and for ...

Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental ...

Compare Dialysis Centers examined CDC data and other sources to explore kidney disease risk factors and why the condition has ...

Currently, doctors sometimes use a drug called spironolactone to treat this condition. It’s a medication that’s been around ...

Swiss pharmaceutical giant Novartis is poised to expand its profile in the San Diego area, announcing plans to acquire ...

New Method Predicts Worsening of Chronic Kidney Disease Sep. 12, 2024 — Researchers have developed a new method that could be a significant step in the treatment of chronic kidney disease.

Researchers from the University of Kentucky have taken a closer look at the relationship between obesity and kidney disease ...

Advancing Chronic kidney disease care in India hinges on integrating modern diagnostics from early biomarker screening to ...

The latest findings provide reassurance for nephrologists who may be hesitant to prescribe these types of medications.